MX2021013377A - Dieta que simula el ayuno (fmd) como una intervencion para la enfermedad de alzheimer (ad). - Google Patents

Dieta que simula el ayuno (fmd) como una intervencion para la enfermedad de alzheimer (ad).

Info

Publication number
MX2021013377A
MX2021013377A MX2021013377A MX2021013377A MX2021013377A MX 2021013377 A MX2021013377 A MX 2021013377A MX 2021013377 A MX2021013377 A MX 2021013377A MX 2021013377 A MX2021013377 A MX 2021013377A MX 2021013377 A MX2021013377 A MX 2021013377A
Authority
MX
Mexico
Prior art keywords
alzheimer
fmd
disease
fasting
intervention
Prior art date
Application number
MX2021013377A
Other languages
English (en)
Inventor
Valter D Longo
Min Wei
Priya Rangan
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of MX2021013377A publication Critical patent/MX2021013377A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un método para tratar la patología asociada a la enfermedad de Alzheimer incluye un paso de identificar un sujeto que tiene una patología asociada a la enfermedad de Alzheimer. Una dieta que simula el ayuno (FMD) se administra al sujeto por un primer periodo. También se proporcionan los métodos para tratar la formación de placa amiloide y/o niveles elevados de proteína tau así como la neuroinflamación.
MX2021013377A 2019-04-30 2020-04-30 Dieta que simula el ayuno (fmd) como una intervencion para la enfermedad de alzheimer (ad). MX2021013377A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962840762P 2019-04-30 2019-04-30
PCT/US2020/030793 WO2020223522A1 (en) 2019-04-30 2020-04-30 Fasting-mimicking diet (fmd) as an intervention for alzheimer's disease (ad)

Publications (1)

Publication Number Publication Date
MX2021013377A true MX2021013377A (es) 2022-04-12

Family

ID=73017771

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013377A MX2021013377A (es) 2019-04-30 2020-04-30 Dieta que simula el ayuno (fmd) como una intervencion para la enfermedad de alzheimer (ad).

Country Status (8)

Country Link
US (1) US20200345053A1 (es)
EP (1) EP3963599A4 (es)
JP (1) JP2022530671A (es)
CN (1) CN114096164A (es)
AU (1) AU2020265244A1 (es)
CA (1) CA3134756A1 (es)
MX (1) MX2021013377A (es)
WO (1) WO2020223522A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080079707A (ko) * 2006-12-28 2008-09-02 김용훈 기능성 식단 제공 방법 및 장치
CN110491449B (zh) * 2012-07-06 2023-08-08 河谷控股Ip有限责任公司 健康护理分析流的管理
US10242756B2 (en) * 2012-09-21 2019-03-26 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
US10015980B2 (en) * 2012-10-22 2018-07-10 University Of Southern California Methods and formulations promoting tissue/organ regeneration, longevity and healthspan
CN114236130A (zh) * 2013-02-12 2022-03-25 南加利福尼亚大学 用于减轻年龄相关症状的膳食包装
US11000057B2 (en) * 2015-05-06 2021-05-11 University Of Southern California Fasting mimicking and enhancing diet for treating hypertension and lipid disorders
KR20180054364A (ko) * 2016-11-15 2018-05-24 삼성전자주식회사 트레이스 데이터를 생성하는 스토리지 장치 및 상기 스토리지 장치의 동작 방법
US20180247713A1 (en) * 2017-02-28 2018-08-30 Steven I Rothman Intelligent Wearable Sensors for Adaptive Health Score Analytics

Also Published As

Publication number Publication date
CN114096164A (zh) 2022-02-25
EP3963599A1 (en) 2022-03-09
WO2020223522A1 (en) 2020-11-05
EP3963599A4 (en) 2023-01-18
AU2020265244A1 (en) 2021-11-18
US20200345053A1 (en) 2020-11-05
JP2022530671A (ja) 2022-06-30
CA3134756A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
KR960704839A (ko) β-아밀로이드 단백질 생성 억제제(Inhibitors of β-amyloid protein production)
EA200401170A1 (ru) Гуманизированные антитела, распознающие бета-амилоидный пептид
MX2018013727A (es) Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.
EA200300637A1 (ru) Гуманизированные антитела, распознающие бета-амилоидный пептид
WO2019186276A8 (en) Antibody-based methods of detecting and treating alzheimer's disease
ATE300052T1 (de) Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden
EA200101251A1 (ru) Предотвращение и терапия амилоидогенной болезни
MX2020007031A (es) Derivados de 1,3,4,5-tetrahidro -2 h-pirido [4,3-b] indol para el tratamiento, alivio o prevención de trastornos asociados con agregados de tau tales como la enfermedad de alzheimer.
MX2017011598A (es) Metodos para tratar proteinopatias.
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
DOP2021000199A (es) ANTICUERPOS CONTRA AMILOIDE-ß CON PIROGLUTAMATO Y USOS DE ESTOS
MA54525A (fr) Anticorps bispécifiques clec12axcd3 et méthodes de traitement d'une maladie
BR112017020769A2 (pt) anticorpo ou fragmento de ligação, seq id no:3 ou seq id no:7, conjugado de anticorpo-fármaco (adc), composição farmacêutica, processo para produzir a composição farmacêutica, kit para diagnosticar um indivíduo que sofre de um distúrbio neurodegenerativo, método para diagnosticar um indivíduo que sofre de um distúrbio neurodegenerativo, uso do anticorpo ou fragmento de ligação, uso ex vivo de um peptídeo t14, método para identificar um agente candidato, ensaio para identificar um agente, método para identificar um agente que modula
MX2021013377A (es) Dieta que simula el ayuno (fmd) como una intervencion para la enfermedad de alzheimer (ad).
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
DE69916632T2 (de) Verwendung von zimtsäurederivaten zur herstellung eines medikamentes zur vorbeugung oder behandlung von erkrankungen die durch einen hohen blutfettspiegel bedingt sind
IL290195A (en) A method for treating Alzheimer's disease by regulating amino acid levels
EA200501620A1 (ru) Лечение состояний, включающих амилоидные бляшки
EP3746057A4 (en) METHOD FOR PREVENTION OR TREATMENT OF ALZHEIMER'S MORBUS
EP4028038A4 (en) PEPTIDE-BASED COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
DE60308066D1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
EA202190359A1 (ru) Способы лечения нейродегенеративных расстройств
MX2020007298A (es) Nuevo metodo para preparar compuesto para formacion de imagenes.
EA202190406A1 (ru) Способы лечения нейродегенеративных расстройств
Rocha et al. Teaching Neuro Images: Spinocerebellar ataxia type 3 presenting with a cock-walk gait phenotype